Journal of Cancer Prevention

eISSN 2288-3657
pISSN 2288-3649

Comparison of titer of GENEDIA® and GastroPanel® on prediction for specific factors

Variable HpIgG titer on GENEDIA® (OD) P-value HpIgG titer on GastroPanel® (EIU) P-value
Atrophic gastritis < 0.001 < 0.001
Present 1.34 ± 1.01 212.29 ± 405.36
Absent 0.86 ± 1.00 107.13 ± 302.80
Intestinal metaplasia < 0.001 < 0.001
Present 1.26 ± 1.01 201.96 ± 408.76
Absent 0.96 ± 1.03 113.05 ± 290.91
Gastric ulcer 0.044 0.033
Present 1.29 ± 1.08 226.27 ± 419.69
Absent 1.09 ± 1.06 145.64 ± 350.09
Duodenal ulcer 0.003 0.708
Present 1.43 ± 1.02 145.20 ± 270.02
Absent 1.08 ± 1.06 156.93 ± 367.55
Gastric dysplastic lesion 0.005 0.029
Control 1.01 ± 1.07 129.93 ± 313.03
Adenoma 1.22 ± 1.01 157.72 ± 336.97
Cancer 1.22 ± 1.06 194.84 ± 429.78
Age (yr) 0.008 0.093
< 40 0.91 ± 1.05 96.43 ± 249.67
40-69 1.18 ± 1.06 170.08 ± 389.41
≥ 70 0.99 ± 1.07 137.04 ± 294.39
Sex 0.156 < 0.001
Male 1.15 ± 1.02 192.95 ± 413.16
Female 1.05 ± 1.13 98.93 ± 249.38

Values are presented as mean ± SD. Values are measured using GENEDIA® (GENEDIA Helicobacter pylori ELISA, Green Cross Co.) and GastroPanel® (GastroPanel ELISA, Biohit Oyj) kits. HpIgG, anti-H. pylori antibody immunoglobulin G; OD, optical density; EIU, enzyme-immunosorbent units.

J Cancer Prev 2024;29:148~156 https://doi.org/10.15430/JCP.24.024
© J Cancer Prev
© Korean Society of Cancer Prevention. / Powered by INFOrang Co., Ltd